Preclinical services to accelerate drug development

IVRS is a leading Swedish Contract Research Organisation (CRO) committed to being your research partner of choice for preclinical services aimed at accelerating drug development.

We pride ourselves on delivering high-quality research and tailored solutions to meet the unique needs of our clients. Our seasoned team provides comprehensive support from early-stage discovery through to late-stage preclinical evaluation.

Our innovative approaches and state-of-the-art facilities ensure that you receive the highest quality service tailored to your specific needs.

In vivo imaging is a powerful window into the world of living organisms, offering unparalleled insights into biological processes. At IVRS, we specialize in providing comprehensive preclinical in vivo imaging services, allowing researchers and scientists to explore, visualize, and analyze dynamic events within the body.

At IVRS, we understand that every step of the drug development process is critical. From initial discovery to eventual market release, it’s imperative to have a solid foundation built on comprehensive preclinical drug validation. Our team of experts specializes in guiding you through this essential phase, helping you make informed decisions that can ultimately lead to safer, more effective drugs.

Understanding how a therapeutic agent is distributed throughout the body is a crucial aspect of drug development. Biodistribution studies shed light on the journey your drug takes once it enters the system. At IVRS, we specialize in providing comprehensive biodistribution studies to ensure that your therapeutic compounds reach their intended targets and meet regulatory standards.

We understand that safety is paramount in drug development. Our preclinical toxicology assessment services are designed to rigorously evaluate the potential toxicity and safety profile of your compounds. With our expert team and state-of-the-art facilities, we help you navigate the complexities of drug development, ensuring that your therapeutic agents are both effective and safe.